GNC Glucosamine False Ad Suits Combined In Md.

Law360, New York (December 19, 2013, 7:45 PM EST) -- The U.S. Judicial Panel on Multidistrict Litigation sided with GNC Corp. on Tuesday and united a trio of class actions alleging its glucosamine-based Triflex dietary supplement doesn’t improve joint mobility or help regenerate cartilage as advertised.

A six-judge panel overruled plaintiffs in suits in California, Florida and Ohio federal courts and centralized the new multidistrict litigation in Maryland, a venue no party had requested.

Transferring it there will put the case before the same judge handling a multidistrict false advertising case against Nutramax Laboratories Inc. over...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.